Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP420302.RAZgYbBjz3GJUj2meTiDVAndU66fGJXtcvr4TQA4h0ciA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP420302.RAZgYbBjz3GJUj2meTiDVAndU66fGJXtcvr4TQA4h0ciA130_assertion type Assertion NP420302.RAZgYbBjz3GJUj2meTiDVAndU66fGJXtcvr4TQA4h0ciA130_head.
- NP420302.RAZgYbBjz3GJUj2meTiDVAndU66fGJXtcvr4TQA4h0ciA130_assertion description "[When studying the relations between the most important clinicopathologic features of breast cancer and the mRNA expression level of both MBDs, we found that oestrogen receptor (OR)-positive breast cancer specimens contained higher levels of MeCP2 mRNA than did OR-negative cancers (P=0.005).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP420302.RAZgYbBjz3GJUj2meTiDVAndU66fGJXtcvr4TQA4h0ciA130_provenance.
- NP420302.RAZgYbBjz3GJUj2meTiDVAndU66fGJXtcvr4TQA4h0ciA130_assertion evidence source_evidence_literature NP420302.RAZgYbBjz3GJUj2meTiDVAndU66fGJXtcvr4TQA4h0ciA130_provenance.
- NP420302.RAZgYbBjz3GJUj2meTiDVAndU66fGJXtcvr4TQA4h0ciA130_assertion SIO_000772 14612906 NP420302.RAZgYbBjz3GJUj2meTiDVAndU66fGJXtcvr4TQA4h0ciA130_provenance.
- NP420302.RAZgYbBjz3GJUj2meTiDVAndU66fGJXtcvr4TQA4h0ciA130_assertion wasDerivedFrom befree-2016 NP420302.RAZgYbBjz3GJUj2meTiDVAndU66fGJXtcvr4TQA4h0ciA130_provenance.
- NP420302.RAZgYbBjz3GJUj2meTiDVAndU66fGJXtcvr4TQA4h0ciA130_assertion wasGeneratedBy ECO_0000203 NP420302.RAZgYbBjz3GJUj2meTiDVAndU66fGJXtcvr4TQA4h0ciA130_provenance.